Infusion of stem cells and specially generated T-cells from same donor improves leukemia survival

In a significant advance for harnessing the immune system to treat leukemias, researchers at Fred Hutchinson Cancer Research Center for the first time have successfully infused large numbers of donor T-cells specific for a key anti-leukemic antigen to prolong survival in high-risk and relapsed leukemia patients after stem cell transplantation.

http://medicalxpress.com/news/2013-02-infusion-stem-cells-specially-t-cells.html